Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
26.38
-0.40 (-1.49%)
Apr 25, 2025, 11:44 AM EDT - Market open
Collegium Pharmaceutical Revenue
In the year 2024, Collegium Pharmaceutical had annual revenue of $631.45M with 11.41% growth. Collegium Pharmaceutical had revenue of $181.95M in the quarter ending December 31, 2024, with 21.51% growth.
Revenue (ttm)
$631.45M
Revenue Growth
+11.41%
P/S Ratio
1.37
Revenue / Employee
$1,768,765
Employees
357
Market Cap
847.64M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 631.45M | 64.68M | 11.41% |
Dec 31, 2023 | 566.77M | 102.83M | 22.17% |
Dec 31, 2022 | 463.93M | 187.07M | 67.56% |
Dec 31, 2021 | 276.87M | -33.15M | -10.69% |
Dec 31, 2020 | 310.02M | 13.32M | 4.49% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.90B |
COLL News
- 1 day ago - Collegium to Report First Quarter 2025 Financial Results on May 8, 2025 - GlobeNewsWire
- 24 days ago - Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine's Annual Meeting - GlobeNewsWire
- 5 weeks ago - Collegium Announces Updates to its Board of Directors and Executive Leadership Team - GlobeNewsWire
- 6 weeks ago - Collegium Announces Poster Presentations at the 2025 National Association of Pediatric Nurse Practitioners National Conference on Pediatric Health Care - GlobeNewsWire
- 6 weeks ago - Collegium Pharmaceutical's Shareholders Might Be In For A Pain-Free 2025 - Seeking Alpha
- 7 weeks ago - Collegium to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Collegium Pharmaceutical, Inc. (COLL) Q4 2024 Earnings Call Transcript - Seeking Alpha